About Globavir

About company

Globavir was founded in 2011 by Dr. Shalabh Gupta. Globavir was built on multiple licenses from Stanford University from multiple different professors and multiple different departments. In 2014, Globavir acquired BioCycive in all stock deal, and BioCycive became a wholly owned subsidiary of Globavir. In 2015, BioCycive's lead program was partnered with Sorrento Therapeutics. In 2016, Globavir partnered its diagnostic test with Bio-Rad.